课题基金 / 基金详情

Assay of Cyclic ADP-ribose and Analysis of Its Target Molecules

Assay of Cyclic ADP-ribose and Analysis of Its Target Molecules
环ADP-核糖的测定及其靶分子分析
批准号:
08557129
负责人:
KATADA Toshiaki
金额:
$6.46万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997

项目摘要

项目成果

KATADA Toshiaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ecto-form NADase activity induced by retinoic acid (RA) in HL-60 cells is due to CD38, which has an amino acid sequence homologous to Aplysia ADP-ribosyl cyclase. CD38 catalyzes not only the hydrolysis of NAD^+, but also the formation and hydrolysis of cyclic ADP-ribose (cADPR), that is a novel mediator or modulator of Ca^<2+> release from intracellular Ca^<2+> stores. In the present study, we developed a radioimmunoassay (RIA) for cADPR measurement and obtained the following findings. 1.Stimulation of RA-differentiated HL-60 cells with anti-CD38 monoclonal antibodies (IgG1-subcless) induced rapid tyrosine phosphorylation of cellular proteins including the c-cbl proto-oncogene product, p120^<c-cbl>. Superoxide formation in response to formyl-Met-Leu-Phe was markedly enhanced by the anti-CD38 mAbs. Fcgamma-II receptors appeared to be involved in the signal transduction pathway mediated through the anti-CD38 mAb-induced tyrosine phosphorylation. 2.CD38 was abundantly present in rat brain in addition to lymphocytes. In primary culture of rat glial cells and neurons, CD38 was most abundantly observed in astrocyte cell surface. Confocal laser microscopic analysis revealed that immunoreactive CD38 and the enzyme activity were localized on the cell surface of astrocytes in a dot-like shape. The cell-surface CD38 was clustered and internalized upon the addition of the enzyme substrates to the cultured astrocytes. This internalization accompanied with the increase of intracellular cADPR.3.An RA response element (RARE) consisting of two directrepeated TGACCT-like hexamer motifs with a 5-nucleotide spacer was found to be located in the first intron of CD38 gene. This RARE interacted with heterodimer composed of RA receptor and retinoid X receptor. Thus, the RA-induced expression of human CD38 gene was demonstrated to be mediated through the RARE located in the first intron. 4.An increase in cellular cADPR was observed upon the fertilization of see urchin eggs.
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Shin-ichi Hoshino, et al.: "Mapping of the catalytic and epitopic sites of human CD38/NADase to a functional domain in the carboxy terminus." J.Immunol.158. 741-747 (1997)
Shin-ichi Hoshino 等人:“将人类 CD38/NADase 的催化位点和表位位点映射到羧基末端的功能域。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Masuda, et al.: "Oscillation of ADP-ribosyl cyclase activity during the cell cycle and function of cyclic ADP-ribose in a unicellusar organism,Euglena gracilis." FEBS Lett.405. 104-106 (1997)
M.Masuda 等人:“细胞周期期间 ADP-核糖基环化酶活性的振荡以及单细胞生物体小眼虫中环状 ADP-核糖的功能。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
30
    Identification of signaling pathways involved in fungal pathogenicity and search for novel targets for antifungal drugs
    • 批准号:
      20K06550
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.75万
    • 财政年份:
      2020
    • 负责人:
      KATADA Toshiaki
    • 依托单位:
    Nutrient response mediated by a TRIM-NHL protein
    A novel signal transduction pathway which regulates the structure of P-body and the dynamics of ARE-mRNAs
    • 批准号:
      22659015
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $1.92万
    • 财政年份:
      2010
    • 负责人:
      KATADA Toshiaki
    • 依托单位:
    Regulation of intracellular vesicle transport by small GTPase cycles
    • 批准号:
      20247011
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $27.46万
    • 财政年份:
      2008
    • 负责人:
      KATADA Toshiaki
    • 依托单位:
    国内基金
    海外基金
    力学刺激调控巨噬细胞CD38/NAD+SIRT1轴促进肩袖损伤修复术后腱骨愈合的机制与验证研究
    • 批准号:
      JCZRLH202602006
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    胆管癌中CD38介导的NAD+耗竭导致SIRT1失活并促进FXR高乙酰化修饰的代谢机制研究
    ABCA1/CD38/NAD+通路诱导巨噬细胞衰老促进子宫内膜异位症进展的机制研究
    • 批准号:
      2026JJ80446
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      曾文
    • 依托单位:
    基于虚拟筛选的CD38小分子抑制剂T67751在鼻咽癌中的作用及其机制研究
    • 批准号:
      2026JJ81933
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      唐婧琼
    • 依托单位: